Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Nautilus achieves milestone in Serono hGH collaboration

Feb. 24, 2005

Ammonul approved for urea cycle disorder

Feb. 23, 2005

Novel DPP-IV inhibitors for type 2 diabetes imparted by Fujisawa

Feb. 22, 2005

Salvat discloses new PPAR receptor modulators

Feb. 22, 2005

Aastrom expands U.S. Tissue Repair Cells study

Feb. 22, 2005

Orally efficacious MCH-1 receptor antagonist tested for the treatment of obesity

Feb. 22, 2005

Boehringer Ingelheim imparts new DPP-IV inhibitors for the treatment of diabetes

Feb. 21, 2005

Xechem makes progress in Nicosan/Hemoxin efforts

Feb. 21, 2005

A subcutaneous histrelin implant shows promise in the treatment of CPP

Feb. 18, 2005

Phase I study of NMI-861, a combined yohimbine/L-arginine treatment for male erectile dysfunction

Feb. 17, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...